20101221: A Single Arm, Open-label, Long-term Efficacy and Safety Study of Romiplostim in Thrombocytopenic Pediatric Subjects With ImmuneThrombocytopenia (ITP)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/15/156/24/18

Funding

  • Amgen, Inc.
  • Amgen, Inc.